Recent

% | $
Quotes you view appear here for quick access.

Johnson & Johnson Message Board

  • marks12343 marks12343 Apr 16, 2013 7:58 AM Flag

    Prescription Drug Winners- especially Xarelto

    I work in the medical profession. I've seen a literal explosion in the number of Xarelto prescriptions.

    Xarelto is a blood thinner that replaced generic coumadin (warfarin). The advantage is that Xarelto does not need any monitoring and is very easy to dose correctly. The disadvantage is that there is no way to reverse Xarelto in case of bleeding. Xarelto appears to be effectively "cheaper" then generic coumadin when factoring in the need to monitor coumadin levels. Xarelto is crushing other alternative blood thinning agents like pradaxa.

    I expect to see massive growth for Xarelto, which should help the JNJ presciption segment achieve nice growth.

    Other J and J prescription winners without any generics yet available:
    Velcade
    Zytiga
    Nucynta
    Remicade
    Procrit
    Prezista
    Invega Sustenna
    Simponi
    Stelara

    Sentiment: Strong Buy

 
JNJ
101.73-0.24(-0.24%)Feb 10 4:00 PMEST